Skip to main content
Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
48.69
-0.77 (-1.56%)
At close: Apr 28, 2026, 4:00 PM EDT
47.69
-1.00 (-2.05%)
After-hours: Apr 28, 2026, 4:54 PM EDT

Supernus Pharmaceuticals Revenue

In the year 2025, Supernus Pharmaceuticals had annual revenue of $718.95M with 8.63% growth. Supernus Pharmaceuticals had revenue of $211.57M in the quarter ending December 31, 2025, with 21.48% growth.

Revenue (ttm)
$718.95M
Revenue Growth
+8.63%
P/S Ratio
3.88
Revenue / Employee
$924,103
Employees
778
Market Cap
2.80B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2025718.95M57.14M8.63%
Dec 31, 2024661.82M54.30M8.94%
Dec 31, 2023607.52M-59.72M-8.95%
Dec 31, 2022667.24M87.46M15.09%
Dec 31, 2021579.78M59.38M11.41%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Bausch Health Companies 10.27B
Perrigo Company 4.25B
Amneal Pharmaceuticals 3.02B
Phibro Animal Health 1.46B
Prestige Consumer Healthcare 1.10B
ANI Pharmaceuticals 883.37M
BioCryst Pharmaceuticals 874.84M
Kiniksa Pharmaceuticals International, 677.56M
Revenue Rankings

SUPN News

More News